Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 541 to 552 of 552 entries
Sorted by: Best Match Show Resources per page
The synergic toxicity of temperature increases and nanopolystrene on zebrafish brain implies that global warming may worsen the current risk based on plastic debris.

The Science of the total environment

Sulukan E, Baran A, Şenol O, Yildirim S, Mavi A, Ceyhun HA, Toraman E, Ceyhun SB.
PMID: 34863762
Sci Total Environ. 2022 Feb 20;808:152092. doi: 10.1016/j.scitotenv.2021.152092. Epub 2021 Dec 02.

Global warming and plastic pollution are among the most important environmental problems today. Unfortunately, our world is warming more than expected and biological life, especially in the oceans, has come to the limit of the struggle for survival with...

Cite
Sulukan E, Baran A, Şenol O, et al. The synergic toxicity of temperature increases and nanopolystrene on zebrafish brain implies that global warming may worsen the current risk based on plastic debris. Sci Total Environ. 2021;808:152092doi: 10.1016/j.scitotenv.2021.152092.
Sulukan, E., Baran, A., Şenol, O., Yildirim, S., Mavi, A., Ceyhun, H. A., Toraman, E., & Ceyhun, S. B. (2022). The synergic toxicity of temperature increases and nanopolystrene on zebrafish brain implies that global warming may worsen the current risk based on plastic debris. The Science of the total environment, 808152092. https://doi.org/10.1016/j.scitotenv.2021.152092
Sulukan, Ekrem, et al. "The synergic toxicity of temperature increases and nanopolystrene on zebrafish brain implies that global warming may worsen the current risk based on plastic debris." The Science of the total environment vol. 808 (2022): 152092. doi: https://doi.org/10.1016/j.scitotenv.2021.152092
Sulukan E, Baran A, Şenol O, Yildirim S, Mavi A, Ceyhun HA, Toraman E, Ceyhun SB. The synergic toxicity of temperature increases and nanopolystrene on zebrafish brain implies that global warming may worsen the current risk based on plastic debris. Sci Total Environ. 2022 Feb 20;808:152092. doi: 10.1016/j.scitotenv.2021.152092. Epub 2021 Dec 02. PMID: 34863762.
Copy Download .nbib Format: NLM
Vesicourachal Diverticulum: A Rare Cause of Recurrent Urinary Tract Infections.

Cureus

Alqarni MA, Kutubkhana RH, Alhosami SM, Almutairi FA, Almutairi AM, Alqannad EM, Almansour MH, Alanazi AA, Althobaiti AM, Althobaiti ZF, Alshehri MA, Malki SZ, Alhasani HM, Alburi MA, Al-Hawaj F.
PMID: 35003961
Cureus. 2021 Dec 02;13(12):e20118. doi: 10.7759/cureus.20118. eCollection 2021 Dec.

Urinary tract infection is a common medical condition encountered in outpatient clinics and emergency departments. Recurrence of urinary tract infections is common. The recurrence can arise from behavioral, mechanical, and physiological factors. Urachal anomalies are very rare congenital clinical...

Cite
Alqarni MA, Kutubkhana RH, Alhosami SM, et al. Vesicourachal Diverticulum: A Rare Cause of Recurrent Urinary Tract Infections. Cureus. 2021;13(12):e20118doi: 10.7759/cureus.20118.
Alqarni, M. A., Kutubkhana, R. H., Alhosami, S. M., Almutairi, F. A., Almutairi, A. M., Alqannad, E. M., Almansour, M. H., Alanazi, A. A., Althobaiti, A. M., Althobaiti, Z. F., Alshehri, M. A., Malki, S. Z., Alhasani, H. M., Alburi, M. A., & Al-Hawaj, F. (2021). Vesicourachal Diverticulum: A Rare Cause of Recurrent Urinary Tract Infections. Cureus, 13(12), e20118. https://doi.org/10.7759/cureus.20118
Alqarni, Mohammed A, et al. "Vesicourachal Diverticulum: A Rare Cause of Recurrent Urinary Tract Infections." Cureus vol. 13,12 (2021): e20118. doi: https://doi.org/10.7759/cureus.20118
Alqarni MA, Kutubkhana RH, Alhosami SM, Almutairi FA, Almutairi AM, Alqannad EM, Almansour MH, Alanazi AA, Althobaiti AM, Althobaiti ZF, Alshehri MA, Malki SZ, Alhasani HM, Alburi MA, Al-Hawaj F. Vesicourachal Diverticulum: A Rare Cause of Recurrent Urinary Tract Infections. Cureus. 2021 Dec 02;13(12):e20118. doi: 10.7759/cureus.20118. eCollection 2021 Dec. PMID: 35003961; PMCID: PMC8723736.
Copy Download .nbib Format: NLM
Nancy Davis Reagan, First Lady with a Neurosurgical Legacy.

World neurosurgery

Houlihan LM, Staudinger Knoll AJ, Jubran JH, Farhadi DS, Benner D, Zabramski JM, Lawton MT, Spetzler RF, Preul MC, Blau I, Barak A.
PMID: 34389521
World Neurosurg. 2021 Nov;155:64-73. doi: 10.1016/j.wneu.2021.08.012. Epub 2021 Aug 11.

Various well-known people associated with the history of the presidency of the United States have experienced neurologic disease or injury, especially trauma to the head or spine. Nancy Reagan, however, as the wife of President Ronald Reagan and First...

Cite
Houlihan LM, Staudinger Knoll AJ, Jubran JH, et al. Nancy Davis Reagan, First Lady with a Neurosurgical Legacy. World Neurosurg. 2021;155:64-73doi: 10.1016/j.wneu.2021.08.012.
Houlihan, L. M., Staudinger Knoll, A. J., Jubran, J. H., Farhadi, D. S., Benner, D., Zabramski, J. M., Lawton, M. T., Spetzler, R. F., Preul, M. C., Blau, I., & Barak, A. (2021). Nancy Davis Reagan, First Lady with a Neurosurgical Legacy. World neurosurgery, 15564-73. https://doi.org/10.1016/j.wneu.2021.08.012
Houlihan, Lena Mary, et al. "Nancy Davis Reagan, First Lady with a Neurosurgical Legacy." World neurosurgery vol. 155 (2021): 64-73. doi: https://doi.org/10.1016/j.wneu.2021.08.012
Houlihan LM, Staudinger Knoll AJ, Jubran JH, Farhadi DS, Benner D, Zabramski JM, Lawton MT, Spetzler RF, Preul MC, Blau I, Barak A. Nancy Davis Reagan, First Lady with a Neurosurgical Legacy. World Neurosurg. 2021 Nov;155:64-73. doi: 10.1016/j.wneu.2021.08.012. Epub 2021 Aug 11. PMID: 34389521.
Copy Download .nbib Format: NLM
Left Ventricular Assist Devices in Patients With Active Malignancies.

JACC. CardioOncology

Schlam I, Lee AY, Li S, Sheikh FH, Zaghlol R, Basyal B, Gallagher C, Molina E, Mahr C, Cheng RK, Barac A.
PMID: 34396339
JACC CardioOncol. 2021 Jun 15;3(2):305-315. doi: 10.1016/j.jaccao.2021.04.008. eCollection 2021 Jun.

BACKGROUND: There are limited data to guide oncology and cardiology decision-making in patients with a left ventricular assist device (LVAD) and concurrent active malignancy.OBJECTIVES: The goal of this study was to describe cancer treatment approaches, complications, and survival among...

Cite
Schlam I, Lee AY, Li S, et al. Left Ventricular Assist Devices in Patients With Active Malignancies. JACC CardioOncol. 2021;3(2):305-315doi: 10.1016/j.jaccao.2021.04.008.
Schlam, I., Lee, A. Y., Li, S., Sheikh, F. H., Zaghlol, R., Basyal, B., Gallagher, C., Molina, E., Mahr, C., Cheng, R. K., & Barac, A. (2021). Left Ventricular Assist Devices in Patients With Active Malignancies. JACC. CardioOncology, 3(2), 305-315. https://doi.org/10.1016/j.jaccao.2021.04.008
Schlam, Ilana, et al. "Left Ventricular Assist Devices in Patients With Active Malignancies." JACC. CardioOncology vol. 3,2 (2021): 305-315. doi: https://doi.org/10.1016/j.jaccao.2021.04.008
Schlam I, Lee AY, Li S, Sheikh FH, Zaghlol R, Basyal B, Gallagher C, Molina E, Mahr C, Cheng RK, Barac A. Left Ventricular Assist Devices in Patients With Active Malignancies. JACC CardioOncol. 2021 Jun 15;3(2):305-315. doi: 10.1016/j.jaccao.2021.04.008. eCollection 2021 Jun. PMID: 34396339; PMCID: PMC8352017.
Copy Download .nbib Format: NLM
Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care.

JACC. CardioOncology

Cheng RK, Kirkpatrick JN, Sorror ML, Barac A.
PMID: 34396199
JACC CardioOncol. 2019 Dec 17;1(2):314-317. doi: 10.1016/j.jaccao.2019.10.003. eCollection 2019 Dec.

No abstract available.

Cite
Cheng RK, Kirkpatrick JN, Sorror ML, et al. Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care. JACC CardioOncol. 2019;1(2):314-317doi: 10.1016/j.jaccao.2019.10.003.
Cheng, R. K., Kirkpatrick, J. N., Sorror, M. L., & Barac, A. (2019). Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care. JACC. CardioOncology, 1(2), 314-317. https://doi.org/10.1016/j.jaccao.2019.10.003
Cheng, Richard K, et al. "Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care." JACC. CardioOncology vol. 1,2 (2019): 314-317. doi: https://doi.org/10.1016/j.jaccao.2019.10.003
Cheng RK, Kirkpatrick JN, Sorror ML, Barac A. Cardio-Oncology and the Intersection of Cancer and Cardiotoxicity: The Role of Palliative Care. JACC CardioOncol. 2019 Dec 17;1(2):314-317. doi: 10.1016/j.jaccao.2019.10.003. eCollection 2019 Dec. PMID: 34396199; PMCID: PMC8352189.
Copy Download .nbib Format: NLM
Cardiovascular Prevention Strategies in Breast Cancer.

JACC. CardioOncology

Yin AB, Brewster AM, Barac A, Thoman W, Oeffinger KC, Gilchrist SC.
PMID: 34396201
JACC CardioOncol. 2019 Dec 17;1(2):322-325. doi: 10.1016/j.jaccao.2019.09.001. eCollection 2019 Dec.

No abstract available.

Cite
Yin AB, Brewster AM, Barac A, et al. Cardiovascular Prevention Strategies in Breast Cancer. JACC CardioOncol. 2019;1(2):322-325doi: 10.1016/j.jaccao.2019.09.001.
Yin, A. B., Brewster, A. M., Barac, A., Thoman, W., Oeffinger, K. C., & Gilchrist, S. C. (2019). Cardiovascular Prevention Strategies in Breast Cancer. JACC. CardioOncology, 1(2), 322-325. https://doi.org/10.1016/j.jaccao.2019.09.001
Yin, Alexandra B, et al. "Cardiovascular Prevention Strategies in Breast Cancer." JACC. CardioOncology vol. 1,2 (2019): 322-325. doi: https://doi.org/10.1016/j.jaccao.2019.09.001
Yin AB, Brewster AM, Barac A, Thoman W, Oeffinger KC, Gilchrist SC. Cardiovascular Prevention Strategies in Breast Cancer. JACC CardioOncol. 2019 Dec 17;1(2):322-325. doi: 10.1016/j.jaccao.2019.09.001. eCollection 2019 Dec. PMID: 34396201; PMCID: PMC8352277.
Copy Download .nbib Format: NLM
Impact of the bronchopulmonary sequestration on endobronchial tuberculosis: the case report and the review of literature.

Journal of infection in developing countries

Adzic-Vukicevic T, Petkovic A, Menkovic N, Stosic M, Bracanovic M, Korica S, Barac A.
PMID: 34898509
J Infect Dev Ctries. 2021 Nov 30;15(11):1766-1769. doi: 10.3855/jidc.15325.

INTRODUCTION: We describe the rare case of endobronchial tuberculosis (EBTB) and chronic pulmonary atelectasis with mediastinal distortion. Finding of the concomitant venous anomaly of inferior vena cava revealed the diagnosis of bronchopulmonary sequestration.CASE REPORT: A 22-year-old Caucasian woman presented...

Cite
Adzic-Vukicevic T, Petkovic A, Menkovic N, et al. Impact of the bronchopulmonary sequestration on endobronchial tuberculosis: the case report and the review of literature. J Infect Dev Ctries. 2021;15(11):1766-1769doi: 10.3855/jidc.15325.
Adzic-Vukicevic, T., Petkovic, A., Menkovic, N., Stosic, M., Bracanovic, M., Korica, S., & Barac, A. (2021). Impact of the bronchopulmonary sequestration on endobronchial tuberculosis: the case report and the review of literature. Journal of infection in developing countries, 15(11), 1766-1769. https://doi.org/10.3855/jidc.15325
Adzic-Vukicevic, Tatjana, et al. "Impact of the bronchopulmonary sequestration on endobronchial tuberculosis: the case report and the review of literature." Journal of infection in developing countries vol. 15,11 (2021): 1766-1769. doi: https://doi.org/10.3855/jidc.15325
Adzic-Vukicevic T, Petkovic A, Menkovic N, Stosic M, Bracanovic M, Korica S, Barac A. Impact of the bronchopulmonary sequestration on endobronchial tuberculosis: the case report and the review of literature. J Infect Dev Ctries. 2021 Nov 30;15(11):1766-1769. doi: 10.3855/jidc.15325. PMID: 34898509.
Copy Download .nbib Format: NLM
Influence of nanostructured alumina coating on the clinical performance of zirconia cantilevered resin-bonded fixed dental prostheses: Up to 3-year results of a prospective, randomized, controlled clinical trial.

The Journal of prosthetic dentistry

Malgaj T, Abram A, Kocjan A, Jevnikar P.
PMID: 34420804
J Prosthet Dent. 2021 Aug 19; doi: 10.1016/j.prosdent.2021.07.003. Epub 2021 Aug 19.

STATEMENT OF PROBLEM: The debonding of zirconia cantilevered resin-bonded fixed dental prostheses remains a technical complication because zirconia's chemical inertness impedes adequate surface preparation for bonding. Limited clinical evidence on the performance of various pretreatment methods for the bonding...

Cite
Malgaj T, Abram A, Kocjan A, et al. Influence of nanostructured alumina coating on the clinical performance of zirconia cantilevered resin-bonded fixed dental prostheses: Up to 3-year results of a prospective, randomized, controlled clinical trial. J Prosthet Dent. 2021;doi: 10.1016/j.prosdent.2021.07.003.
Malgaj, T., Abram, A., Kocjan, A., & Jevnikar, P. (2021). Influence of nanostructured alumina coating on the clinical performance of zirconia cantilevered resin-bonded fixed dental prostheses: Up to 3-year results of a prospective, randomized, controlled clinical trial. The Journal of prosthetic dentistry, . https://doi.org/10.1016/j.prosdent.2021.07.003
Malgaj, Tine, et al. "Influence of nanostructured alumina coating on the clinical performance of zirconia cantilevered resin-bonded fixed dental prostheses: Up to 3-year results of a prospective, randomized, controlled clinical trial." The Journal of prosthetic dentistry vol. (2021). doi: https://doi.org/10.1016/j.prosdent.2021.07.003
Malgaj T, Abram A, Kocjan A, Jevnikar P. Influence of nanostructured alumina coating on the clinical performance of zirconia cantilevered resin-bonded fixed dental prostheses: Up to 3-year results of a prospective, randomized, controlled clinical trial. J Prosthet Dent. 2021 Aug 19; doi: 10.1016/j.prosdent.2021.07.003. Epub 2021 Aug 19. PMID: 34420804.
Copy Download .nbib Format: NLM
Socio-demographic disparities in amblyopia prevalence among 1.5 million adolescents.

European journal of public health

Nitzan I, Bez M, Megreli J, Bez D, Barak A, Yahalom C, Levine H.
PMID: 34518882
Eur J Public Health. 2021 Dec 01;31(6):1211-1217. doi: 10.1093/eurpub/ckab111.

BACKGROUND: Amblyopia, when not diagnosed at appropriate age, leads to uncorrectable visual impairment with considerable social and financial implications. The aim of this study was to assess socio-demographic disparities in amblyopia prevalence among Israeli adolescents, in order to identify...

Cite
Nitzan I, Bez M, Megreli J, et al. Socio-demographic disparities in amblyopia prevalence among 1.5 million adolescents. Eur J Public Health. 2021;31(6):1211-1217doi: 10.1093/eurpub/ckab111.
Nitzan, I., Bez, M., Megreli, J., Bez, D., Barak, A., Yahalom, C., & Levine, H. (2021). Socio-demographic disparities in amblyopia prevalence among 1.5 million adolescents. European journal of public health, 31(6), 1211-1217. https://doi.org/10.1093/eurpub/ckab111
Nitzan, Itay, et al. "Socio-demographic disparities in amblyopia prevalence among 1.5 million adolescents." European journal of public health vol. 31,6 (2021): 1211-1217. doi: https://doi.org/10.1093/eurpub/ckab111
Nitzan I, Bez M, Megreli J, Bez D, Barak A, Yahalom C, Levine H. Socio-demographic disparities in amblyopia prevalence among 1.5 million adolescents. Eur J Public Health. 2021 Dec 01;31(6):1211-1217. doi: 10.1093/eurpub/ckab111. PMID: 34518882.
Copy Download .nbib Format: NLM
Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors.

Circulation research

Fleming MR, Xiao L, Jackson KD, Beckman JA, Barac A, Moslehi JJ.
PMID: 34110908
Circ Res. 2021 Jun 11;128(12):1973-1987. doi: 10.1161/CIRCRESAHA.121.318259. Epub 2021 Jun 10.

Novel targeted cancer therapies have revolutionized oncology therapies, but these treatments can have cardiovascular complications, which include heterogeneous cardiac, metabolic, and vascular sequelae. Vascular side effects have emerged as important considerations in both cancer patients undergoing active treatment and...

Cite
Fleming MR, Xiao L, Jackson KD, et al. Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors. Circ Res. 2021;128(12):1973-1987doi: 10.1161/CIRCRESAHA.121.318259.
Fleming, M. R., Xiao, L., Jackson, K. D., Beckman, J. A., Barac, A., & Moslehi, J. J. (2021). Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors. Circulation research, 128(12), 1973-1987. https://doi.org/10.1161/CIRCRESAHA.121.318259
Fleming, Matthew R, et al. "Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors." Circulation research vol. 128,12 (2021): 1973-1987. doi: https://doi.org/10.1161/CIRCRESAHA.121.318259
Fleming MR, Xiao L, Jackson KD, Beckman JA, Barac A, Moslehi JJ. Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors. Circ Res. 2021 Jun 11;128(12):1973-1987. doi: 10.1161/CIRCRESAHA.121.318259. Epub 2021 Jun 10. PMID: 34110908.
Copy Download .nbib Format: NLM
CLIP and Massively Parallel Functional Analysis of CELF6 Reveal a Role in Destabilizing Synaptic Gene mRNAs through Interaction with 3' UTR Elements.

Cell reports

Rieger MA, King DM, Crosby H, Liu Y, Cohen BA, Dougherty JD.
PMID: 33357440
Cell Rep. 2020 Dec 22;33(12):108531. doi: 10.1016/j.celrep.2020.108531.

CELF6 is a CELF-RNA-binding protein, and thus part of a protein family with roles in human disease; however, its mRNA targets in the brain are largely unknown. Using cross-linking immunoprecipitation and sequencing (CLIP-seq), we define its CNS targets, which...

Cite
Rieger MA, King DM, Crosby H, et al. CLIP and Massively Parallel Functional Analysis of CELF6 Reveal a Role in Destabilizing Synaptic Gene mRNAs through Interaction with 3' UTR Elements. Cell Rep. 2020;33(12):108531doi: 10.1016/j.celrep.2020.108531.
Rieger, M. A., King, D. M., Crosby, H., Liu, Y., Cohen, B. A., & Dougherty, J. D. (2020). CLIP and Massively Parallel Functional Analysis of CELF6 Reveal a Role in Destabilizing Synaptic Gene mRNAs through Interaction with 3' UTR Elements. Cell reports, 33(12), 108531. https://doi.org/10.1016/j.celrep.2020.108531
Rieger, Michael A, et al. "CLIP and Massively Parallel Functional Analysis of CELF6 Reveal a Role in Destabilizing Synaptic Gene mRNAs through Interaction with 3' UTR Elements." Cell reports vol. 33,12 (2020): 108531. doi: https://doi.org/10.1016/j.celrep.2020.108531
Rieger MA, King DM, Crosby H, Liu Y, Cohen BA, Dougherty JD. CLIP and Massively Parallel Functional Analysis of CELF6 Reveal a Role in Destabilizing Synaptic Gene mRNAs through Interaction with 3' UTR Elements. Cell Rep. 2020 Dec 22;33(12):108531. doi: 10.1016/j.celrep.2020.108531. PMID: 33357440; PMCID: PMC7780154.
Copy Download .nbib Format: NLM
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial.

The Lancet. Respiratory medicine

Rabe KF, Celli BR, Wechsler ME, Abdulai RM, Luo X, Boomsma MM, Staudinger H, Horowitz JE, Baras A, Ferreira MA, Ruddy MK, Nivens MC, Amin N, Weinreich DM, Yancopoulos GD, Goulaouic H.
PMID: 34302758
Lancet Respir Med. 2021 Nov;9(11):1288-1298. doi: 10.1016/S2213-2600(21)00167-3. Epub 2021 Jul 21.

BACKGROUND: Genetic data implicate IL-33 in asthma susceptibility. Itepekimab, a monoclonal antibody targeting IL-33, demonstrated clinical activity in asthma, with potential in chronic obstructive pulmonary disease (COPD). In this study we first aimed to test the hypothesis that genetic...

Cite
Rabe KF, Celli BR, Wechsler ME, et al. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. Lancet Respir Med. 2021;9(11):1288-1298doi: 10.1016/S2213-2600(21)00167-3.
Rabe, K. F., Celli, B. R., Wechsler, M. E., Abdulai, R. M., Luo, X., Boomsma, M. M., Staudinger, H., Horowitz, J. E., Baras, A., Ferreira, M. A., Ruddy, M. K., Nivens, M. C., Amin, N., Weinreich, D. M., Yancopoulos, G. D., & Goulaouic, H. (2021). Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. The Lancet. Respiratory medicine, 9(11), 1288-1298. https://doi.org/10.1016/S2213-2600(21)00167-3
Rabe, Klaus F, et al. "Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial." The Lancet. Respiratory medicine vol. 9,11 (2021): 1288-1298. doi: https://doi.org/10.1016/S2213-2600(21)00167-3
Rabe KF, Celli BR, Wechsler ME, Abdulai RM, Luo X, Boomsma MM, Staudinger H, Horowitz JE, Baras A, Ferreira MA, Ruddy MK, Nivens MC, Amin N, Weinreich DM, Yancopoulos GD, Goulaouic H. Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial. Lancet Respir Med. 2021 Nov;9(11):1288-1298. doi: 10.1016/S2213-2600(21)00167-3. Epub 2021 Jul 21. PMID: 34302758.
Copy Download .nbib Format: NLM
Showing 541 to 552 of 552 entries